In GBM, VRK1 depletion impaired the formation of H4K20me2 that is required for the recruitment of 53BP1 to damaged DNA sites in glioblastoma cells treated with temozolomide and olaparib [39]. This evidence concerns the gene VRK1 and glioblastoma.